Clinical Trials on Non-Neurogenic Bladder
Total 19865 results
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Japan, Netherlands, India, Canada, Czechia, Mexico, Australia, Portugal
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Moldova, Republic of, Romania, Ukraine
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruiting
-
ImmunityBio, Inc.Active, not recruiting
-
University of OklahomaEMD SeronoCompletedBladder CancerUnited States
-
Jørgen Bjerggaard JensenCepheidActive, not recruitingNon-muscle Invasive Bladder Cancer | Urinary BiomarkerDenmark
-
UroGen Pharma Ltd.TerminatedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel, Russian Federation, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Ukraine
-
Samyang Biopharmaceuticals CorporationTerminatedNon Muscle Invasive Bladder CancerKorea, Republic of
-
Mayo ClinicRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Ferring PharmaceuticalsRecruiting
-
University College, LondonAstraZeneca; ShionogiRecruitingBladder CancerUnited Kingdom
-
Sesen Bio, Inc.CompletedBladder CancerUnited States, Canada
-
Mansoura UniversityRecruitingNon-Muscle Invasive Bladder CancerEgypt
-
Mansoura UniversityRecruitingNon-Muscle Invasive Bladder CancerEgypt
-
Institut Paoli-CalmettesNot yet recruitingNon-muscle-invasive Bladder Cancer
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingNon-muscle-invasive Bladder CancerChina
-
Jørgen Bjerggaard JensenUniversity of AarhusRecruitingNon-Muscle Invasive Bladder CancerDenmark
-
Paolo PuppoCompletedNon Muscle Invasive Bladder CancerItaly
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedRecurrent Bladder Carcinoma | Stage I Bladder Cancer | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial CarcinomaUnited States
-
Aadi Bioscience, Inc.National Cancer Institute (NCI)CompletedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
University of OxfordMerck Sharp & Dohme LLCTerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United Kingdom
-
Ulrich MehnertInstitut Guttmann; Schweizerisches Paraplegikerzentrum Nottwil; BG Unfallklinik... and other collaboratorsWithdrawnSpinal Cord Injury | Neurogenic Detrusor OveractivitySwitzerland, Spain
-
West China HospitalRemeGen Co., Ltd.Not yet recruitingNon-muscle Invasive Bladder CancerChina
-
Jørgen Bjerggaard JensenNovo Nordisk A/S; University of AarhusRecruitingNon-muscle Invasive Bladder CancerDenmark, Norway, Latvia
-
Memorial Sloan Kettering Cancer CenterRockefeller University; Pin Down Bladder Cancer Research FoundationRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
ImmunityBio, Inc.RecruitingNon-muscle Invasive Bladder CancerUnited States
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy
-
UNICANCERHoffmann-La RocheActive, not recruitingBladder CancerSpain, France, Belgium
-
University of Rome Tor VergataUniversity of BariCompleted
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer...Active, not recruitingBladder CancerAustralia, United Kingdom
-
University Hospital Inselspital, BerneUniversity of Bern; Hospital Centre Biel/BienneRecruitingBladder Cancer | Non-muscle InvasiveSwitzerland
-
RECORDATI GROUPCompletedNeurogenic Detrusor OveractivityCzechia, France, Poland, Portugal
-
Taris Biomedical LLCCompletedNeurogenic Detrusor OveractivityUnited States
-
University of WashingtonPatient-Centered Outcomes Research InstituteActive, not recruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Cancer of the Bladder, RecurrentUnited States
-
Rick Hansen InstituteUniversity of British Columbia; Vancouver Coastal Health; International Collaboration...CompletedBotox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCIAutonomic DysreflexiaCanada
-
Toronto Rehabilitation InstituteOntario Neurotrauma FoundationCompletedSpinal Cord Injury | Neurogenic Detrusor OveractivityCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Incyte CorporationRecruitingBladder Cancer | NMIBC | Urothelial Carcinoma Recurrent | Non-Muscle Invasive Bladder CancerUnited States
-
CepheidAxonal-Biostatem; Stève ConsultantsCompletedNon-muscle-invasive Bladder CancerUnited Kingdom, Netherlands, Spain, Sweden, Austria, Germany, Czechia, France, Italy
-
BioCis Pharma LtdTurku University Hospital; FinnMedi Oy; Tampere University HospitalCompletedCis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder CancerNon-muscle Invasive Bladder CancerFinland
-
Istituto Oncologico Veneto IRCCSFidia Farmaceutici s.p.a.Not yet recruiting
-
Fudan UniversityNot yet recruitingNon-muscle Invasive Bladder Cancer | HER-2 Protein Overexpression
-
Swiss Paraplegic Centre NottwilCompletedNeurogenic Lower Urinary Tract DysfunctionSwitzerland
-
UroGen Pharma Ltd.Active, not recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Spain, Lithuania, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Austria
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder NeoplasmsKorea, Republic of, United States, Argentina, Belgium, Brazil, China, Poland, United Kingdom, Italy, Japan, Germany, Romania
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Bladder Urothelial Carcinoma | Bladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Superficial Bladder Urothelial CarcinomaUnited States
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage 0is Bladder Urothelial Carcinoma | Stage I Bladder Urothelial Carcinoma | Stage 0 Bladder Urothelial CarcinomaUnited States
-
Sandy SrinivasGlaxoSmithKlineCompletedBladder Cancer | Bladder (Urothelial, Transitional Cell) Cancer | Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) | Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) | Bladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableUnited States